#1 Clinical Trials Search in Europe

Retroperitoneal fibrosis – Diagnostics

Go back

Retroperitoneal fibrosis is a rare condition that often goes unnoticed in its early stages, but timely and accurate diagnosis can be life-changing for patients. Understanding when to seek testing and what diagnostic methods are available helps people recognize symptoms early and work with their healthcare team to prevent serious complications.

Introduction: Who Should Undergo Diagnostics

Knowing when to seek medical attention for retroperitoneal fibrosis can make a significant difference in treatment outcomes. Since this condition develops slowly and its symptoms are often vague and nonspecific, many people may not realize they need testing until the disease has progressed.[1]

Anyone experiencing persistent dull pain in the belly, lower back, or sides should consider seeing a healthcare provider, especially if the pain is difficult to pinpoint or gradually worsens over time. This type of discomfort is one of the earliest signs that something may be affecting the area behind the abdominal cavity.[1] If you have testicles, pain in that area can also be an important warning sign that should not be ignored.

You should seek diagnostic testing urgently if you notice a significant decrease in how much urine you produce each day. Low urine output combined with abdominal or lower back pain may indicate that the tubes carrying urine from your kidneys to your bladder are being compressed, which can lead to kidney damage if not addressed quickly.[1] Other warning signs include leg swelling, changes in leg color, difficulty moving your legs, or swelling in the scrotum.

It is worth noting that some people with retroperitoneal fibrosis have no symptoms at all in the early stages.[1] This means the condition may be discovered accidentally during medical imaging done for unrelated reasons.[2] This is why regular health check-ups are valuable, particularly if you have risk factors for the disease.

⚠️ Important
Retroperitoneal fibrosis most commonly affects males between 40 and 60 years old, though it can occur in people of any age and in females as well.[1] If you fall into this age group and have other risk factors such as exposure to asbestos or use of tobacco products, you should be particularly alert to symptoms and discuss them with your doctor early.

Certain factors increase your likelihood of developing this condition, making diagnostic testing even more important if symptoms appear. People who smoke tobacco products or have been exposed to asbestos at work face higher risk. Having both risk factors together increases your chances even more, though avoiding even one of them can help reduce your risk.[1]

If you are taking certain medications, you should also be aware that they can sometimes trigger retroperitoneal fibrosis. Beta-blockers, which are drugs used to treat heart disease like propranolol, metoprolol, and atenolol, have been linked to the condition. Other medications that may cause it include dopamine antagonists used for mental health disorders and nausea, hydralazine tablets for high blood pressure, migraine medications containing ergotamine, and certain pain medications.[1] If you are on any of these drugs and notice symptoms, inform your doctor so they can consider whether diagnostic testing is needed.

Additionally, anyone who has had radiation therapy in the past, experienced abdominal trauma or surgery, or has been diagnosed with cancer such as Hodgkin or non-Hodgkin lymphoma should discuss the possibility of retroperitoneal fibrosis with their healthcare provider if concerning symptoms develop.[1]

Classic Diagnostic Methods

Diagnosing retroperitoneal fibrosis requires a combination of clinical evaluation and specialized testing. Because the symptoms are often nonspecific and the condition is rare, healthcare providers must carefully piece together information from multiple sources to reach an accurate diagnosis.[2]

Physical Examination and Medical History

The diagnostic process typically begins with a thorough physical examination and discussion of your medical history. Your healthcare provider will press gently on your belly to check for any abnormal masses or areas of tenderness.[1] They will also measure your blood pressure, as approximately half of patients with retroperitoneal fibrosis develop high blood pressure due to the condition.[5]

During this visit, your doctor will ask about your symptoms in detail, including when they started, how they have changed over time, and whether anything makes them better or worse. They will also inquire about any medications you take, your work history (particularly any asbestos exposure), whether you use tobacco products, and whether you have had any past surgeries, radiation therapy, or cancer diagnoses. All of this information helps guide the diagnostic process.

Laboratory Blood Tests

Blood tests play an important role in evaluating retroperitoneal fibrosis, though they cannot diagnose the condition on their own. These tests help detect early signs of complications and provide clues about inflammation in your body.[1]

One of the most important blood tests measures kidney function by checking levels of urea and creatinine in your blood. When the fibrous tissue blocks the tubes that drain urine from your kidneys, these waste products can build up, indicating that your kidneys are not working properly.[5] Elevated levels signal that the condition may already be affecting your kidneys.

Your healthcare provider will also check for signs of inflammation by measuring your erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level. These markers are typically elevated when there is active inflammation in your body, which is common with retroperitoneal fibrosis.[5] High levels suggest that the inflammatory process is ongoing and may influence treatment decisions.

A complete blood count is performed to check for anemia, which means having a low number of red blood cells. Many people with retroperitoneal fibrosis develop anemia as a complication of the disease.[5] Blood tests may also reveal elevated levels of alkaline phosphatase, another marker that has been reported in some patients.[5]

In some cases, doctors test for antinuclear antibodies (ANA), which are present in about 60 percent of people with this condition.[5] The presence of these antibodies suggests that the immune system may be involved in causing the disease. Other blood work might show polyclonal hypergammaglobulinemia, an increase in certain immune proteins that can appear with inflammatory conditions.[5]

Urine Tests

Urinalysis, which is the examination of your urine, is usually normal in people with retroperitoneal fibrosis. However, in rare cases, it may show microscopic amounts of blood (hematuria) or signs of infection (pyuria).[5] While not typically helpful for diagnosis, urine tests help rule out other conditions that might cause similar symptoms.

Imaging Studies

Imaging tests are the cornerstone of diagnosing retroperitoneal fibrosis. They allow doctors to see the fibrous tissue mass, determine its size and location, assess how severely it is affecting surrounding structures, and evaluate kidney function.[1]

Kidney ultrasound may be the first imaging test performed if your symptoms suggest kidney disease. This test uses sound waves to create pictures of your kidneys and can show signs of blockage or swelling.[1] However, ultrasound has limitations and often leads to additional testing with more detailed imaging methods.

CT scan (computed tomography) is one of the most frequently used imaging methods for diagnosing retroperitoneal fibrosis. Healthcare providers typically prefer CT scans because they provide excellent detail of the retroperitoneal space.[1] A CT scan can measure the severity of fibrosis, show how well your kidneys are functioning, and reveal whether the ureters are being compressed or blocked. The test creates cross-sectional images of your body using X-rays and computer processing, allowing doctors to see a confluent mass surrounding the aorta and common iliac arteries, which are major blood vessels in your abdomen.[6]

MRI (magnetic resonance imaging) is another preferred imaging method that provides detailed pictures without using radiation. Instead, MRI uses powerful magnets and radio waves to create images of soft tissues.[1] On MRI scans, retroperitoneal fibrosis typically shows low signal intensity on T1-weighted images and variable signal on T2-weighted images.[6] MRI is particularly useful for distinguishing benign (non-cancerous) fibrosis from malignant (cancerous) masses. Malignant fibrosis tends to appear bulky, extend above where the kidney arteries branch off, displace the aorta forward, and less frequently push the ureters inward compared to non-cancerous fibrosis.[6]

Nuclear medicine imaging and PET scans (positron emission tomography) may also be used in certain situations. A PET scan using fludeoxyglucose (FDG) can show areas where the tracer accumulates in the affected tissue, indicating active disease.[6] These tests help assess how active the inflammatory process is and can be useful for monitoring response to treatment.

A pyelogram is a special type of X-ray that focuses on the urinary system. It involves injecting a contrast dye into your bloodstream that travels to your kidneys and urinary tract, making them visible on X-ray images. This test can clearly show blockages in the ureters.[1] However, pyelograms are used more often during management of a blockage that has already been identified rather than for initial diagnosis.

Biopsy

A biopsy involves taking a small sample of the fibrous tissue to examine it under a microscope. While not always required for diagnosis, a biopsy becomes necessary in certain situations.[1] Your doctor may recommend a biopsy if treatments are not working as expected, if there are concerns that cancer might be causing the fibrosis, if the location of the fibrous tissue is unusual, or if imaging findings are unclear.[7]

The biopsy is usually performed as a day-case procedure, meaning you can go home the same day. Using imaging guidance such as ultrasound or CT, a doctor identifies the affected area in your back and guides a needle into position. A small sliver of tissue is removed and sent to a laboratory for examination.[7] This procedure is generally very safe, though like most medical procedures, it carries a small risk of complications.

It is important to understand that a biopsy does not always provide enough tissue or clear enough information to confirm the diagnosis. For this reason, doctors carefully weigh the potential benefits against the risks before recommending a biopsy. This decision should be made through discussion between you and your specialist, with input from family members or caregivers if you wish.[7]

The main purpose of a biopsy is to exclude malignancy, meaning to make sure that cancer is not the cause of the retroperitoneal fibrosis.[5] Approximately one-third of cases of retroperitoneal fibrosis are secondary to cancer, medications, prior radiotherapy, or certain infections, so confirming the diagnosis is important for planning appropriate treatment.[6]

Diagnostics for Clinical Trial Qualification

When people with retroperitoneal fibrosis are considered for participation in clinical trials, they undergo additional diagnostic assessments beyond those used for standard clinical care. Clinical trials are research studies that test new treatments or approaches to managing the condition, and they require very specific criteria to ensure the safety of participants and the accuracy of the study results.

The standard diagnostic criteria used for enrolling patients in clinical trials typically include confirmation of the diagnosis through imaging studies. CT scans and MRI are the most commonly required tests because they provide objective measurements of the fibrotic mass size and location.[1] Clinical trial protocols often specify minimum or maximum sizes for the fibrous tissue mass or particular anatomical locations that must be involved.

Blood tests measuring kidney function are usually required for clinical trial participation. Since retroperitoneal fibrosis commonly affects the kidneys, trials need to document the extent of kidney impairment at the beginning of the study. Tests measuring urea and creatinine levels help establish baseline kidney function.[5] Some trials may set specific thresholds, accepting only patients with mild kidney impairment while excluding those with severe kidney failure.

Inflammatory markers such as ESR and CRP are often measured as part of clinical trial screening. These tests help confirm that there is active inflammation present, which may be important if the trial is testing anti-inflammatory treatments.[5] Trials may require these values to be above certain levels to ensure participants have active disease that can respond to treatment.

For clinical trials investigating treatments related to immune system function, additional specialized blood tests may be required. These might include checking for antinuclear antibodies or measuring levels of immunoglobulin G4 (IgG4), since some cases of retroperitoneal fibrosis are associated with IgG4-related disease.[2] Understanding the underlying immune processes helps researchers select appropriate participants for specific types of immunosuppressive treatments being studied.

⚠️ Important
If you are interested in participating in a clinical trial for retroperitoneal fibrosis, your healthcare team will explain the specific diagnostic tests required. These requirements ensure that researchers can accurately measure whether the experimental treatment is working and that all participants are safe throughout the study.

A tissue biopsy may be mandatory for some clinical trials, particularly those testing new medications where excluding malignancy is critical.[5] Even if you have already been diagnosed with retroperitoneal fibrosis through imaging, a trial protocol might require histological confirmation, which means examining tissue under a microscope. This ensures that all participants truly have the same condition and that no one with cancer is mistakenly enrolled.

Clinical trials often require more frequent monitoring than standard care, which means additional diagnostic tests throughout the study period. Participants typically undergo repeat CT or MRI scans at scheduled intervals to measure changes in the size of the fibrous mass. Regular blood tests track kidney function and inflammatory markers to assess response to treatment. These repeated assessments provide the data researchers need to determine whether the experimental treatment is effective.

Some trials may also use specialized imaging techniques like PET scans to measure disease activity more precisely.[6] These advanced tests help researchers understand not just the size of the fibrous tissue, but also how metabolically active it is, which can indicate whether inflammation is decreasing with treatment.

It is important to note that clinical trial eligibility criteria vary widely depending on what is being studied. Some trials focus on newly diagnosed patients, while others may accept only those who have already tried standard treatments without success. Your doctor can help you understand whether you meet the criteria for any available clinical trials and whether participation might be beneficial for you.

Ongoing Clinical Trials on Retroperitoneal fibrosis

References

https://my.clevelandclinic.org/health/diseases/23168-retroperitoneal-fibrosis

https://www.ncbi.nlm.nih.gov/books/NBK482409/

https://www.webmd.com/a-to-z-guides/what-is-retroperitoneal-fibrosis

https://medlineplus.gov/genetics/condition/retroperitoneal-fibrosis/

https://emedicine.medscape.com/article/458501-overview

https://en.wikipedia.org/wiki/Retroperitoneal_fibrosis

https://www.ukkidney.org/rare-renal/patient-information-0/retroperitoneal-fibrosis

More information about
Retroperitoneal fibrosis:

FAQ

Can retroperitoneal fibrosis be detected before symptoms appear?

Yes, in some cases retroperitoneal fibrosis is discovered accidentally during imaging studies performed for completely unrelated reasons.[2] Some people have no symptoms at all in the early stages, which means the condition can remain hidden until it causes complications or is found incidentally.[1]

Why is CT scan preferred over ultrasound for diagnosing this condition?

While ultrasound can show signs of kidney blockage or swelling, CT scan and MRI are preferred because they provide much more detailed images of the retroperitoneal space.[1] These advanced imaging methods can measure the severity of fibrosis, show the exact location and size of the fibrous mass, and clearly visualize how it is affecting surrounding organs and blood vessels.[1]

Do all patients with retroperitoneal fibrosis need a biopsy?

No, not everyone needs a biopsy. This procedure is typically recommended only when treatments are not working as expected, when there are concerns about cancer being the cause, when the location of fibrosis is unusual, or when imaging results are unclear.[1] The decision to perform a biopsy is made through careful discussion between the patient and their specialist.[7]

Are blood tests alone enough to diagnose retroperitoneal fibrosis?

No, blood tests cannot diagnose retroperitoneal fibrosis on their own because the results are nonspecific.[5] However, they provide important information about kidney function, inflammation levels, and possible immune system involvement, all of which help guide diagnosis and treatment decisions when combined with imaging studies.[1]

How can doctors tell if the fibrosis is caused by cancer or is benign?

Imaging characteristics on MRI can help distinguish benign from malignant causes. Malignant retroperitoneal fibrosis tends to appear bulky, extend higher in the abdomen, push the aorta forward, and less often push the ureters inward compared to benign fibrosis.[6] However, when there is doubt, a biopsy may be needed to examine the tissue under a microscope and confirm whether cancer cells are present.[5]

🎯 Key takeaways

  • • Seek medical attention if you have persistent dull abdominal, back, or flank pain, especially combined with decreased urine output, as these are early warning signs.
  • • Retroperitoneal fibrosis most commonly affects males aged 40 to 60, though it can occur in anyone, and risk increases with smoking or asbestos exposure.
  • • CT scan and MRI are the preferred imaging methods for diagnosis, providing detailed views that ultrasound cannot match.
  • • Blood tests measuring kidney function and inflammation markers help assess complications but cannot diagnose the condition alone.
  • • A biopsy is not always necessary and is typically reserved for cases where cancer is suspected or treatment is not working.
  • • Some people have no symptoms in early stages, and the condition may be discovered accidentally during imaging for other reasons.
  • • Clinical trials require specific diagnostic criteria including imaging confirmation and baseline measurements of kidney function and inflammatory markers.
  • • Certain medications including beta-blockers, migraine drugs, and pain medications can trigger the condition, so inform your doctor about all medications you take.